Abstract
Purpose: To develop low-molecular-weight methylcellulose (LMw MC)-based gel/Pluronic F127 micelle combination system for local and sustained delivery of docetaxel (DTX). Methods: LMw MC and Pluronic F127 were used to formulate an injectable thermo-reversible gel/micelle combination system containing DTX. The DTX-loaded combination system was characterized and its therapeutic efficacy evaluated in a subcutaneous tumor model. Results: Mixtures of LMw MC, AS, and Pluronic F127 formed gel at ~15-40° C depending on AS concentration. The combination system released DTX for >30 days with a biphasic and sustained release pattern, and DTX stability was maintained during release. The combination system significantly enhanced anti-cancer effects of DTX and prolonged survival of the model mouse in comparison with free DTX. Conclusions: The LMw MC gel/Pluronic F127 micelle combination system constitutes a promising tool for reducing tumor size and eradicating remaining tumor cells before and after surgery.
Original language | English (US) |
---|---|
Pages (from-to) | 525-534 |
Number of pages | 10 |
Journal | Pharmaceutical Research |
Volume | 29 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2012 |
Externally published | Yes |
Keywords
- Cancer therapy
- Docetaxel
- Drug delivery
- Gel/micelle combination system
- Methylcellulose
ASJC Scopus subject areas
- Biotechnology
- Molecular Medicine
- Pharmacology
- Pharmaceutical Science
- Organic Chemistry
- Pharmacology (medical)